耐药结核病防治需紧跟大数据时代的步伐

doi:10.3969/j.issn.1000-6621.2019.12.001

中国防痨杂志 ›› 2019, Vol. 41 ›› Issue (12): 1237-1240.doi: 10.3969/j.issn.1000-6621.2019.12.001

• 专家论坛 • 下一篇

耐药结核病防治需紧跟大数据时代的步伐

方勇,肖和平()

200433同济大学附属上海市肺科医院结核病临床研究中心上海市结核病(肺)重点实验室

收稿日期:2019-10-25 出版日期:2019-12-10 发布日期:2019-12-13
通信作者: 肖和平 E-mail:xiaoheping_sars@163.com

Drug-resistant TB prevention needs to keep pace with the era of big data

Yong FANG,He-ping XIAO()

Clinic and Research Center of Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medine, Shanghai 200433,China

Received:2019-10-25 Online:2019-12-10 Published:2019-12-13
Contact: He-ping XIAO E-mail:xiaoheping_sars@163.com

摘要/Abstract

摘要：

耐药结核病防治的任务紧迫与手段匮乏之间的矛盾日益突出,对精准诊疗迫切需求。大数据在疾病的预防、诊断和治疗中的应用已经形成了一个良好的开端,所起到的作用也越来越大,也是耐药结核病现代化的防治工作中所不可或缺的。我们需把握大数据时代的脉搏,积极地实现数据共享、数据集约和数据保护,注重卫生信息技术领域相关人才的培养。

关键词: 结核, 结核, 抗多种药物性, 医学信息学应用, 综合预防, 诊断, 综合疗法, 大数据

Abstract:

The contradiction between the task of the prevention and control of drug-resistant tuberculosis and the lack of means is becoming more and more prominent, and the need for accurate diagnosis and treatment is also urgent. The application of the big data in the prevention, diagnosis and treatment of the disease has formed a good beginning, and the effect is also becoming more and more important, and it is also indispensable in the prevention and treatment of the modernization of drug-resistant tuberculosis. We need to grasp the pulse of the big data era, actively realize data sharing, data intensive and data protection, and pay attention to the cultivation of relevant talents in the field of health information technology.

Key words: Tuberculosis, Tuberculosis, multidrug-resistant, Medical informatics applications, Universal precautions, Diagnosis, Combined modality therapy, Big data

方勇,肖和平. 耐药结核病防治需紧跟大数据时代的步伐[J]. 中国防痨杂志, 2019, 41(12): 1237-1240. doi: 10.3969/j.issn.1000-6621.2019.12.001

Yong FANG,He-ping XIAO. Drug-resistant TB prevention needs to keep pace with the era of big data[J]. Chinese Journal of Antituberculosis, 2019, 41(12): 1237-1240. doi: 10.3969/j.issn.1000-6621.2019.12.001

参考文献 18

[1]	Anema A, Kluberg S, Wilson K , et al. Digital surveillance for enhanced detection and response to outbreaks. Lancet Infect Dis, 2014,14(11):1035-1037.
[2]	Davidson MW, Haim DA, Radin JM . Using networks to combine “big data” and traditional surveillance to improve influenza predictions. Sci Rep, 2015,5:8154.
[3]	Leff DR, Yang GZ . Big Data for Precision Medicine. Engineering, 2015,1(3):277-279.
[4]	Kim GD, Noh MS, Kim CH , et al. Fitting competing risks models using medical big data from tuberculosis patients. Korean J Applied Statistics, 2018,31(4):529-538.
[5]	Jokonya O . Towards a Big Data Framework for the prevention and control of HIV/AIDS, TB and Silicosis in the mining industry//Centeris 2014-Conference on Enterprise Information Systems/Projman 2014-International Conference on Project Management/Hcist 2014-International Conference on Health and Social Care Information Systems and Technologies. Procedia Computer Science series volume 16(Available online at www.sciencedirect.com). Amsterdam:Elsevier, 2014: 1533-1541.
[6]	Cabral DJ, Wurster JI, Belenky P . Antibiotic Persistence as a Metabolic Adaptation: Stress, Metabolism, the Host, and New Directions. Pharmaceuticals (Basel), 2018,11(1). pii:E14.
[7]	温保江, 周正华, 梁志勇 , 等. 基于大数据建立临床肺结核综合诊断数学模型的研究. 结核病与肺部健康杂志, 2018,7(1):23-28.
[8]	Chen Y, Guzauskas GF, Gu C , et al. Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to Value. J Pers Med, 2016, 6(4). pii:E20.
[9]	Adhil M, Gandham S, Talukder AK , et al. CuraEx-Clinical Expert System Using Big-Data for Precision Medicine. Big Data Analytics(BDA), 2015,LNCS 9498: 216-227.
[10]	Denny JC, Van Driest SL, Wei WQ , et al. The Influence of Big (Clinical) Data and Genomics on Precision Medicine and Drug Development. Clin Pharmaco Ther, 2018,103(3):409-418.
[11]	Ekins S, Freundlich JS, Reynolds RC . Are bigger data sets better for machine learning? fusing single-point and dual-event dose response data for Mycobacterium tuberculosis. J Chem Inf Model, 2014,54(7):2157-2165.
[12]	房宏霞 . 从互联网到大数据——结核病患者管理面临的机遇与挑战. 中国防痨杂志, 2017,39(7):677-678.
[13]	Yu KH, Hart SN, Goldfeder R , et al. Harnessing big data for precision medicine: infrastructures and applications. Pac Symp Biocomput, 2017,22:635-639.
[14]	Longo DL, Drazen JM . Data sharing. N Engl J Med, 2016,374(3):276-277.
[15]	Alamri A . Big Data with integrated cloud computing for prediction of health conditions//2019 International Conference on Platform Technology and Service (Platcon). Cheju:Institution of Creative Research Professionals, 2019: 40-45.
[16]	Hopp WJ, Li J, Wang GH . Big Data and the Precision Medicine Revolution. Product Operat Manag, 2018,27(9):1647-1664.
[17]	Ullah F, Babar MA . An architecture-driven adaptation approach for big data cyber security analytics//2019 IEEE International Conference on Software Architecture (ICSA). Hamburg:IEEE Computer Society, 2019: 41-50.
[18]	Shanmugapriya E, Kavitha R . Medical big data analysis: preserving security and privacy with hybrid cloud technology. Soft Computing, 2019,23(8): 2585-2596. .

耐药结核病防治需紧跟大数据时代的步伐

Drug-resistant TB prevention needs to keep pace with the era of big data

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 18

相关文章 15

编辑推荐

Metrics

本文评价

友情链接

[1]	刘晓莉, 雷丽梅, 郭周莉, 黄殷, 徐静, 赵霞, 王燕, 付莉. 结核病患者产生病耻感与领悟社会支持的相关性研究[J]. 中国防痨杂志, 2020, 42(9): 1002-1008.
[2]	中国防痨协会学术工作委员会《中国防痨杂志》编辑委员会. 抗结核药品固定剂量复合制剂的临床使用专家共识[J]. 中国防痨杂志, 2020, 42(9): 885-893.
[3]	靳鸿建. 我国县级结核病防治服务体系建设及防治工作亟需加强——一位老防痨工作者的意见和建议[J]. 中国防痨杂志, 2020, 42(9): 896-902.
[4]	张灿有, 夏辉, 成君. Ⅱ级生物安全柜在结核病实验室中的检测及报告要求[J]. 中国防痨杂志, 2020, 42(9): 903-909.
[5]	周林, 刘二勇, 孟庆琳, 陈明亭, 周新华, 高微微, 林明贵, 谢汝明. 《WS 288—2017 肺结核诊断》标准实施后肺结核诊断质量评估分析[J]. 中国防痨杂志, 2020, 42(9): 910-915.
[6]	刘二勇, 王前, 周林, 张国钦, 张修磊, 马永成, 杨枢敏, 王毳, 孟庆琳, 陈明亭, 林明贵, 屠德华. 我国部分地区病原学检测阴性肺结核诊断质量现状分析[J]. 中国防痨杂志, 2020, 42(9): 916-920.
[7]	孟庆琳, 李进岚, 林定文, 马永成, 侯双翼, 刘年强, 周林. 结核病防治从业人员对新的结核病标准相关知识知晓情况调查分析[J]. 中国防痨杂志, 2020, 42(9): 921-925.
[8]	王前, 周林, 刘二勇, 赵雁林, 李涛, 陈明亭, 杨丽佳, 王嘉. 我国县级结核病定点医疗机构结核病诊断能力现况调查研究[J]. 中国防痨杂志, 2020, 42(9): 926-930.
[9]	李婷, 何金戈, 苏茜, 李京, 李运葵, 高文凤, 高媛, 杨文. 结核菌素试验在四川省布拖县HIV感染/AIDS患者中筛查结核感染的价值[J]. 中国防痨杂志, 2020, 42(9): 931-936.
[10]	李运葵, 何金戈, 苏茜, 李婷, 李京, 高文凤, 杨文, 毛光玉. 结核病症状筛查在四川省布拖县HIV感染/AIDS患者中发现结核病患者的价值[J]. 中国防痨杂志, 2020, 42(9): 937-941.
[11]	苏茜, 夏勇, 逯嘉, 王丹霞, 何金戈. 2009—2018年四川省0~14 岁儿童肺结核流行特征分析[J]. 中国防痨杂志, 2020, 42(9): 942-947.
[12]	邓亚丽, 张天华, 刘卫平, 张宏伟, 马煜, 李鹏. 2014—2018年陕西省肺结核发病的时空聚集性分析[J]. 中国防痨杂志, 2020, 42(9): 948-955.
[13]	董晓, 赵珍, 刘年强, 王森路, 崔燕. 2009—2017年新疆维吾尔自治区老年肺结核发现特征分析[J]. 中国防痨杂志, 2020, 42(9): 956-961.
[14]	梁瑞云, 方伟军, 任会丽, 黎惠如, 张晖. 非结核分枝杆菌肺病并发与未并发糖尿病患者的CT征象研究[J]. 中国防痨杂志, 2020, 42(9): 962-967.
[15]	马廷龙, 韩毅, 程序, 刘志东. 超声抗结核药品电导入联合化疗对胸壁结核的疗效观察[J]. 中国防痨杂志, 2020, 42(9): 968-972.